A Phase 1 Open-label Clinical Trial of Optimized Peptelligence(Rm) Oral Leuprolide
Latest Information Update: 21 Oct 2021
At a glance
- Drugs Leuprorelin (Primary)
- Indications Endometriosis
- Focus Adverse reactions
- Sponsors Enteris BioPharma
- 21 Oct 2021 New trial record
- 04 Oct 2021 Results presented in the Enteris BioPharma Media Release.